ProKidney (PROK) Earnings Date & Reports

ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PROK is expected to report earnings to -14 cents per share on August 06

Q2'26

Est.

$-0.14

Q4'25

Beat

by $0.01

Q3'25

Beat

by $0.03

Q2'25

Beat

by $0.02

Q1'25

Beat

by $0.03

The last earnings report on March 18 showed earnings per share of -14 cents, beating the estimate of -15 cents. With 117.25K shares outstanding, the current market capitalization sits at 359.10M.

View a ticker or compare two or three

Compare

PROK

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for PROK